SCHEMBL20149057

SCHEMBL20149057

CC(=O)N1CCC(C(=O)N2C[C@@H](Cc3cccc4ccccc34)[C@H](c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)C2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RORC P51449 19/20 1.00
NR1I2 O75469 3/20 0.52
TACR1 P25103 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23713117 0.86 RORC (1.00) RORCNR1I2TACR1
SCHEMBL23713066 0.85 RORC (1.00) RORCNR1I2
SCHEMBL23713056 0.82 RORC (1.00) RORCNR1I2TACR1
SCHEMBL23713088 0.79 RORC (1.00) RORCNR1I2
SCHEMBL20149050 0.78 RORC (0.84) RORCNR1I2TACR1
SCHEMBL23713089 0.77 RORC (1.00) RORC
SCHEMBL20140231 0.74 RORC (0.69) RORCNR1I2
SCHEMBL20139664 0.74 RORC (0.69) RORCNR1I2
SCHEMBL23713055 0.74 RORC (1.00) RORC
SCHEMBL23713050 0.72 RORC (1.00) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078186-B2 ROR γ modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-03 US disclosed
WO-2018089406-A1 ROR GAMMA MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078186-B2 ROR γ modulators RORB, RORC, RORA RORC 2/4885NR1I2 7/4885TACR1 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.